FORMULATION, DEVELOPMENT, EVALUATION OF CALCITRIOL AND CLOBETASOL

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 1

Abstract

Psoriasis vulgaris is a common skin disorder characterized by focal formation of inflamed, raised plaques that constantly shed scales derived from excessive growth of skin epithelial cells. Prevalence of Psoriasis is 2-3 % in general population. Currently, Topical Corticosteroids remain a pivotal treatment due to their effective anti-inflammatory properties; however potential adverse effects associated with chronic application limit long-term continuous therapy. Vitamin D analogues provide another mechanism of action reducing lesions through effects on keratinocytes and on cytokine environment. A topical combination of corticosteroid & Vitamin D derivative appears to provide a balanced approach to psoriasis treatment. When Calcitriol is used in combination with topical steroids, some improvement in psoriasis treatment was observed. The main side effect of Calcitriol is skin irritation. Topical steroids Clobetasol used in conjunction with Calcitriol may lessen skin irritation. Combination reduces hazards associated with long term use of topical Corticosteroids (atrophy and rebound) as well as irritation associated with Calcipotriol. Various formulations of Calcitriol (0.0003%) and Clobetasol Propionate (0.05%) were taken for optimization in relation to ointment base, consistency, ointment stability, stability with antioxidant, stability with different preservatives, and effect of temperature of Calcitriol phase addition to bulk white petrolatum base of ointment. Observations of all formulations for physical characterization and drug release profile had shown that, all comply with the specifications of official pharmacopeias and or standard reference. It was observed that, formulation batch- F12 selected as optimized formulation of Ointment, as it fulfills all requirements of Topical ointment.

Authors and Affiliations

Pasupathi A, Palanisamy P, B Jaykar, R Margret Chandira, B S Venkateswarlu

Keywords

Related Articles

IN-VIVO ANTI-INFLAMMATORYACTIVITY OF METHANOLIC EXTRACT OF CISSUS VITIGINEA

The present investigation deals with the in-vivo acute toxicity studies and in-vivo anti-inflammatory activity by Carrageenan induced rat paw edema model of methanolic extract in the stems of Cissus Vitiginea. The Lite...

Development and validation of stability-indicating UV spectrophotometric method for determination of Apremilast in bulk and pharmaceutical dosage form

A simple, precise, accurate, cost effective stability indicating UVSpectrophotometric method has been developed for the estimation of Apremilast in bulk and tablet dosage form. Apremilast shows highest λmax at 229.3 nm....

Design and development of buccal tablets of Metoprolol tartarate by core in cup technology

A precise, simple, cost effective, accurate Ultra violet spectrophotometric method has been developed for the determination of Edoxaban Tosylate Monohydrate (EDTM) in the Pharmaceutical dosage form. EDTM shows highest...

FORMULATION, CHARACTERIZATION AND IN-VITRO DISSOLUTION STUDIES OF DICLOFENAC SODIUM TABLETS THROUGH SOLID DISPERSION USING POLY ETHYLENE GLYCOL

In the present study the formulation of Diclofenac sodium tablet from poly ethylene glycol solid dispersion has been carried to enhance the bioavailability and solubility of the drug, Diclofenac. The post compression s...

Evaluation of cardioprotective activity of maceration extract of Elettaria cardamomum in doxorubicin induced cardiotoxicity in rats

The plant of Elletteria cardamom was collected and phytochemical studies were made with different solvents using ethanol and water. The extracts showed different extractive values (2.0 and 9.0 respectively) and showed...

Download PDF file
  • EP ID EP33016
  • DOI -
  • Views 538
  • Downloads 0

How To Cite

Pasupathi A, Palanisamy P, B Jaykar, R Margret Chandira, B S Venkateswarlu (2013). FORMULATION, DEVELOPMENT, EVALUATION OF CALCITRIOL AND CLOBETASOL. Indian Journal of Research in Pharmacy and Biotechnology, 1(1), -. https://europub.co.uk/articles/-A-33016